Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Tat'ána Majerová-UhlíkováJan Konvalinka

Abstract

The introduction of HIV proteinase inhibitors (PIs) as anti-AIDS drugs resulted in decreased mortality and prolonged life expectancy of HIV-positive patients. However, rapid selection of drug-resistant HIV variants is a common complication in patients undergoing highly active anti-retroviral therapy (HAART). Thus, monitoring of clinical resistance development is indispensable for rational pharmacotherapy. We present a non-infectious cell-based assay for drug resistance quantification of HIV proteinase (PR) - an important target of HAART. Previously, we showed [Lindsten K, Uhlikova T, Konvalinka J, Masucci MG, Dantuma NP. Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity. Antimicrob Agents Chemother 2001;45:2616-22] that the expression of a fusion protein (GFP-PR), comprised of HIV-1 proteinase wild-type artificial precursor (PR) and green fluorescent protein (GFP), in transiently transfected tissue culture cells depends on the presence of PR-specific inhibitors (PIs). Here we show that in the GFP-PR reporter the HIV wild-type PR can be replaced by a drug-resistant HIV PR mutant, yielding a simple and biologically relevant tool for the quantitative analysis of drug-resistant HIV PR mutants s...Continue Reading

References

Jan 1, 1979·Methods in Enzymology·J W Williams, J F Morrison
Aug 31, 1990·Biochemical and Biophysical Research Communications·L H PhylipA V Broadhurst
Jun 6, 1995·Biochemical and Biophysical Research Communications·H L ShamT Robins
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·J W Erickson, S K Burt
Dec 3, 1998·Antimicrobial Agents and Chemotherapy·H L ShamD W Norbeck
Jul 16, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·H WalterK Uberla
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C J PetropoulosJ M Whitcomb
Jun 19, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J Lu, D R Kuritzkes
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·K LindstenN P Dantuma
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Niko BeerenwinkelJoachim Selbig
Oct 9, 2002·The Journal of Biological Chemistry·Raquel BlancoIván Ventoso
Nov 5, 2003·Medicinal Research Reviews·Joseph Sebastian, Hawazin Faruki
Mar 12, 2004·The Journal of Antimicrobial Chemotherapy·Douglas D Richman
May 15, 2004·AIDS Patient Care and STDs·Michael Kozal
Oct 7, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Africa HolguínVincent Soriano
Dec 2, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ebi C BiléJohn N Nkengasong
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Valentina SvicherCarlo Federico Perno
Jun 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman

❮ Previous
Next ❯

Citations

Sep 28, 2012·Journal of Clinical Microbiology·Maria C PuertasJavier Martinez-Picado
Oct 14, 2011·The Journal of Antimicrobial Chemotherapy·Maria José BuzonJavier Martinez-Picado
Jul 12, 2018·Scientific Reports·Jana HumpolíčkováTaťána Majerová

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.